Shreerang A Bhide

The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.

Rafal Panek, Kevin J Harrington, S. Bhide, 2017, The British journal of radiology.

Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.

Kevin J Harrington, S. Bhide, K. Harrington, 2010, International journal of radiation oncology, biology, physics.

Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.

Ulrike Schick, Kevin J Harrington, Sarah L Gulliford, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Emma Hall, Kevin J Harrington, S. Bhide, 2011, The Lancet. Oncology.

Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.

Dualta McQuaid, Kevin J Harrington, Sarah L Gulliford, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.

Ulrike Schick, Kevin J Harrington, Sarah Gulliford, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.